Promentis Pharmaceuticals Inc
Major Drugs - Milwaukee, WI, US
Promentis Pharmaceuticals Inc Employees
Promentis Pharmaceuticals Inc Details
Seeking To Redefine What Is Possible®Promentis Pharmaceuticals, Inc., is a privately held biopharmaceutical company focused on the discovery and development of first-in-class therapies to treat central nervous system (CNS) disorders.Promentis' drug development program is focused on activating a unique target known to restore glutamatergic neurotransmission and imbalances in oxidative stress, key contributors to impaired cortical function linked to multiple CNS disorders.The Company's lead compound, SXC-2023, is being developed to treat various psychiatric disorders, with an initial focus on an indication that, despite representing a common disorder affecting millions of patients, has no FDA-approved treatment and a high level of patient need.
Promentis Pharmaceuticals Inc Technologies
Email Providers
Outlook
Load Balancers
Apache
Tag Management
Google Tag Manager
Fonts
Google Font API
Other
Mobile Friendly